ArticleInternational immunopharmacology2021

Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway.

Xiaoling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.